Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

ABBV

Abbvie Inc

Oct 10 • 03:04PM ET

193.43

Dollar change -1.32
Percentage change -0.68	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: AMGN BIIB BMY GILD JNJ LLY MRK PFE REGN VRTX

| Held by: VTI VOO SPY IVV VTV XLV SCHD VIG VYM VHT

Scroll to Statements

Index	S&P 500	P/E	64.70	EPS (ttm)	2.99	Insider Own	0.09%	Shs Outstand	1.77B	Perf Week	-1.03%
Market Cap	341.66B	Forward P/E	16.00	EPS next Y	12.09	Insider Trans	-18.02%	Shs Float	1.76B	Perf Month	-0.60%
Income	5.30B	PEG	7.99	EPS next Q	2.94	Inst Own	73.02%	Short Float	0.84%	Perf Quarter	13.60%
Sales	55.00B	P/S	6.21	EPS this Y	-2.20%	Inst Trans	1.21%	Short Ratio	3.15	Perf Half Y	15.47%
Book/sh	3.84	P/B	50.40	EPS next Y	11.25%	ROA	3.82%	Short Interest	14.86M	Perf Year	29.91%
Cash/sh	7.45	P/C	25.97	EPS next 5Y	8.10%	ROE	53.93%	52W Range	135.85 - 199.95	Perf YTD	24.82%
Dividend Est.	6.17 (3.19%)	P/FCF	19.26	EPS past 5Y	-5.77%	ROI	8.17%	52W High	-3.26%	Beta	0.62
Dividend TTM	6.13 (3.17%)	Quick Ratio	0.71	Sales past 5Y	11.76%	Gross Margin	69.31%	52W Low	42.38%	ATR (14)	2.99
Dividend Ex-Date	Oct 15, 2024	Current Ratio	0.81	EPS Y/Y TTM	-38.66%	Oper. Margin	31.96%	RSI (14)	48.45	Volatility	1.33% 1.59%
Employees	50000	Debt/Eq	10.42	Sales Y/Y TTM	-1.83%	Profit Margin	9.63%	Recom	1.77	Target Price	201.13
Option/Short	Yes / Yes	LT Debt/Eq	8.56	EPS Q/Q	-32.44%	Payout	220.33%	Rel Volume	0.33	Prev Close	194.75
Sales Surprise	3.14%	EPS Surprise	3.29%	Sales Q/Q	4.31%	Earnings	Oct 30 BMO	Avg Volume	4.71M	Price	193.43
SMA20	-0.41%	SMA50	-0.21%	SMA200	10.31%	Trades		Volume	1,333,024	Change	-0.68%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-24	Upgrade	HSBC Securities	Hold → Buy	$185
May-17-24	Initiated	Cantor Fitzgerald	Overweight	$200
Jan-29-24	Upgrade	William Blair	Mkt Perform → Outperform
Dec-18-23	Downgrade	HSBC Securities	Buy → Hold
Dec-11-23	Upgrade	Goldman	Neutral → Buy
Nov-09-23	Initiated	Deutsche Bank	Hold	$150
Oct-30-23	Upgrade	Barclays	Equal Weight → Overweight	$160 → $170
Oct-20-23	Resumed	UBS	Neutral	$157 → $150
Sep-29-23	Initiated	Raymond James	Outperform	$177
Jul-25-23	Initiated	William Blair	Mkt Perform
Jul-14-23	Initiated	HSBC Securities	Buy	$167
Apr-05-23	Downgrade	Argus	Buy → Hold
Mar-01-23	Initiated	Guggenheim	Buy	$172
Feb-22-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Feb-10-23	Upgrade	SVB Securities	Underperform → Market Perform	$135 → $153
Nov-18-22	Initiated	Credit Suisse	Outperform	$170
Nov-08-22	Downgrade	Societe Generale	Buy → Hold
Aug-01-22	Downgrade	Atlantic Equities	Overweight → Neutral	$178 → $162
May-23-22	Initiated	SVB Leerink	Underperform	$140
May-06-22	Downgrade	Daiwa Securities	Outperform → Neutral	$150

Show Previous Ratings

Today 10:50AM	AbbVie Shares Rebound After Six-day Slump Despite Ongoing Challenges (GuruFocus.com)
Oct-09-24 12:10PM	Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:00AM	AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Oct-06-24 05:50AM	3 Magnificent Dividend Stocks to Buy in October (Motley Fool)
04:31AM	Billionaires Are Loading Up on This High-Yield Dividend Stock. Should You? (Motley Fool)
06:15AM	Loading…
Oct-05-24 06:15AM	2 Top Dividend Stocks Yielding 3% or More to Buy Without Hesitation Right Now (Motley Fool)
Oct-04-24 09:00AM	FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket (PR Newswire)
09:00AM	Allergan Aesthetics and Girls Inc. Celebrate Six Years and Challenge You to Take the Pledge to Support Mentorship in STEM (PR Newswire)
01:52AM	AbbVies atogepant set to reach projected worth of $766m in 2026 after accepted NDA from FDA (Clinical Trials Arena)
Oct-03-24 05:45PM	AbbVie (ABBV) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
04:16PM	AbbVie cuts 2024 profit forecast citing R&D expenses (Reuters)
12:36PM	Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal (Benzinga)
10:10AM	PGIM Jennison Health Sciences Fund Sold AbbVie (ABBV) in Q2. Heres Why (Insider Monkey)
08:30AM	Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. (Investor's Business Daily)
Oct-02-24 08:00AM	Available Nationwide: JUVDERM VOLUMA XC for Moderate to Severe Temple Hollowing (PR Newswire)
07:30AM	Loading…
07:30AM	5 Best Dividend Growth Stocks to Buy in October (Motley Fool)
07:13AM	Blue Shield of California sidesteps PBMs with new Humira biosimilar deal (Healthcare Dive)
05:00AM	Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now (Quartz)
Oct-01-24 08:00AM	The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value (GuruFocus.com)
08:00AM	AbbVie to Host Third-Quarter 2024 Earnings Conference Call (PR Newswire)
Sep-30-24 12:23PM	AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years (Insider Monkey)
09:30AM	Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It? (Zacks)
07:00AM	AbbVie seeks FDA approval for non-small cell lung cancer treatment (Pharmaceutical Business Review)
06:15AM	15 Best Dividend Stocks for Lifelong Passive Income (Motley Fool)
Sep-27-24 02:19PM	Final Trades: Meta, Accenture, Abbvie and Disney (CNBC TV)
02:06PM	15 Unhealthiest Countries in Latin America (Insider Monkey)
12:13PM	AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer (PR Newswire)
11:30AM	Analyst Report: AbbVie Inc. (Morningstar Research)
10:13AM	Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. (Barrons.com)
09:00AM	Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know (Zacks)
06:52AM	Loading…
06:52AM	AbbVies $8.7bn Parkinsons disease drug shines in Phase III trial (Clinical Trials Arena)
Sep-26-24 11:14AM	AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease (Benzinga)
08:30AM	Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead (Motley Fool)
08:07AM	AbbVie's Parkinson's disease drug meets main goal in late-stage trial (Reuters)
08:00AM	AbbVie Announces Positive Topline Results from Phase 3 TEMPO-1 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease (PR Newswire)
08:00AM	AbbVie and SpinUp Foster Canadian Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award (PR Newswire)
04:52AM	AbbVies RINVOQ shows promise in two Phase III atopic dermatitis trials (Clinical Trials Arena)
Sep-25-24 05:45PM	AbbVie (ABBV) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
07:00AM	New Analysis Demonstrates the Efficacy of RINVOQ (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement (PR Newswire)
Sep-24-24 08:00AM	Empowering Women Entrepreneurs: 2024 BOTOX (onabotulinumtoxinA) Cosmetic Grant Recipients Kick Off Crowdfunding Campaigns (PR Newswire)
Sep-23-24 08:26AM	EMA CHMP recommends AbbVie's mirvetuximab soravtansine for ovarian cancer (Pharmaceutical Business Review)
Sep-20-24 07:32AM	AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine (ELAHERE) for the Treatment of Certain Adult Ovarian Cancer (PR Newswire)
Sep-19-24 08:00AM	2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure? (Investor's Business Daily)
04:21AM	2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again (Motley Fool)
Sep-17-24 05:45PM	AbbVie (ABBV) Stock Dips While Market Gains: Key Facts (Zacks)
08:00AM	Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc (GuruFocus.com)
Sep-16-24 01:53PM	Final Trades: TransDigm, BJ's Wholesale, AbbVie and the SMH (CNBC TV)
07:00AM	Can AbbVie Regain Its Status As a Top Dividend Growth Stock? (Motley Fool)
Sep-14-24 09:15AM	Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More (Motley Fool)
07:30AM	3 Stocks to Buy and Hold Forever (Motley Fool)
05:51AM	Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever (Motley Fool)
Sep-13-24 09:30AM	AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
05:15AM	Is This Company Still a Strong Buy After Tripling the S&P 500's Returns? (Motley Fool)
Sep-12-24 03:45PM	A migraine drug ad featuring Serena Williams got called out by the FDA (Quartz)
09:00AM	Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock (Zacks)
Sep-11-24 05:05PM	Is Meta Platforms Inc (NASDAQ:META) the Best AI Stock to Buy According to Carolina Panthers Owner Tepper? (Insider Monkey)
04:29PM	Why Analysts Are Bullish on AbbVie Inc. (ABBV) (Insider Monkey)
08:30AM	Allergan Aesthetics Launches BOTOX Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China (PR Newswire)
Sep-10-24 07:00AM	Health Canada Approves AbbVie's CONSTELLA® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients 6 to 17 Years of Age (PR Newswire)
Sep-09-24 05:45PM	Why AbbVie (ABBV) Outpaced the Stock Market Today (Zacks)
12:05PM	3 Things You Need to Know if You Buy AbbVie Stock Today (Motley Fool)
09:00AM	AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High Unmet Needs (PR Newswire)
Sep-08-24 07:30AM	3 No-Brainer Dividend Stocks to Buy in September (Motley Fool)
03:56AM	Meta Platforms, Inc. (META): Why Are Hedge Funds Bullish On This ESG Stock Now? (Insider Monkey)
Sep-06-24 10:13AM	AbbVie Declares Quarterly Dividend (PR Newswire)
Sep-05-24 04:50AM	Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever (Motley Fool)
Sep-04-24 09:15AM	New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth (GlobeNewswire)
08:00AM	AbbVie's VRAYLAR® (cariprazine) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for the Treatment of Schizophrenia (PR Newswire)
07:00AM	iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs (GlobeNewswire)
Sep-03-24 11:32PM	Is AbbVie Inc. (ABBV) the Best Cancer Stock to Buy Now? (Insider Monkey)
05:45PM	AbbVie (ABBV) Gains As Market Dips: What You Should Know (Zacks)
09:17AM	Moderna, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring (Barrons.com)
08:00AM	The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value (GuruFocus.com)
12:00AM	Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring (Barrons.com)
Sep-02-24 05:07PM	AbbVie Inc (ABBV): A Good 52-Week High Stock to Buy According to Short Sellers (Insider Monkey)
08:45AM	2 Dividend Stocks You Can Safely Hold Through a Recession (Motley Fool)
Sep-01-24 05:53AM	2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer (Motley Fool)
Aug-30-24 10:38AM	Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory (Insider Monkey)
09:45AM	2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher (Motley Fool)
06:45AM	3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever (Motley Fool)
04:20AM	2 Incredibly Cheap Healthcare Stocks to Buy Now (Motley Fool)
Aug-29-24 09:00AM	AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know (Zacks)
05:50AM	Bull Market Buys: 3 Dividend Stocks to Own for the Long Run (Motley Fool)
Aug-28-24 11:16AM	As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors (Benzinga)
06:32AM	Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock (Motley Fool)
Aug-27-24 08:15AM	AbbVie Awards Scholarships to 45 U.S. Students Living With Chronic Immune-Mediated Diseases (PR Newswire)
08:05AM	SkinMedica Revolutionizes Skin Hydration with the Introduction of HA5 Hydra Collagen Replenish + Restore Hydrator (PR Newswire)
Aug-26-24 01:53PM	Meta Platforms, Inc. (META): A Good Technology Stock To Buy For Long Term (Insider Monkey)
05:46AM	Donald Trump Owns These 21 Dividend Kings. Should You? (Motley Fool)
Aug-25-24 06:30PM	3 Unstoppable Dividend Stocks to Buy Right Now (Motley Fool)
Aug-23-24 08:04AM	Analysis: Ozempic on Wall Street's list for 2027 Medicare drug negotiations (Reuters)
Aug-20-24 09:44AM	AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use (Zacks)
08:00AM	AbbVie Inc: An Exploration into Its Intrinsic Value (GuruFocus.com)
04:33AM	EC approves AbbVies TEPKINLY for follicular lymphoma (Pharmaceutical Technology)
Aug-19-24 02:05PM	European Commission Grants Second Indication Approval for TEPKINLY (epcoritamab) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma (PR Newswire)
Aug-18-24 05:50AM	3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More (Motley Fool)
03:19AM	These 3 Healthcare Companies Had the Top-Selling Drugs Last Year (Motley Fool)
Aug-17-24 03:58PM	Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now? (Insider Monkey)
10:00AM	3 High-Yielding Dividend Growth Stocks That Retirees Can Rely On for Recurring Income (Motley Fool)
Aug-15-24 05:30PM	These 10 drugs will be cheaper after Medicare negotiations (Yahoo Finance Video)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hudson Thomas J	Officer	Aug 08 '24	Proposed Sale	189.08	49,170	9,297,210		Aug 08 05:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Aug 05 '24	Sale	186.52	66,500	12,403,580	446,599	Aug 07 05:00 PM
Hudson Thomas J	Officer	Aug 07 '24	Proposed Sale	187.62	101,886	19,115,380		Aug 07 04:22 PM
GONZALEZ RICHARD A	Officer	Aug 05 '24	Proposed Sale	187.36	66,500	12,459,360		Aug 05 10:54 AM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Option Exercise	77.49	282,845	21,919,048	795,944	Jul 19 04:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Sale	175.00	282,845	49,497,875	513,099	Jul 19 04:40 PM
Donoghoe Nicholas	EVP, CHIEF BUS/STRAT OFFICER	Mar 20 '24	Sale	176.30	21,082	3,716,757	55,903	Mar 22 05:00 PM
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 18 '24	Option Exercise	61.36	26,110	1,602,110	119,890	Mar 20 05:00 PM
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 18 '24	Sale	178.79	58,949	10,539,508	60,941	Mar 20 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Mar 01 '24	Option Exercise	61.36	45,700	2,804,152	89,517	Mar 05 05:30 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Mar 01 '24	Sale	177.27	75,680	13,415,503	13,837	Mar 05 05:30 PM
Reents Scott T	EVP, CHIEF FINANCIAL OFFICER	Feb 23 '24	Option Exercise	61.36	14,140	867,630	41,205	Mar 01 05:50 PM
Reents Scott T	EVP, CHIEF FINANCIAL OFFICER	Feb 23 '24	Sale	177.44	14,140	2,509,002	27,065	Mar 01 05:50 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 29 '24	Sale	176.65	5,144	908,688	6,983	Mar 01 05:50 PM
Michael Robert A.	PRES & CHIEF OPERATING OFFICER	Feb 29 '24	Option Exercise	58.30	21,560	1,257,012	167,524	Mar 01 05:50 PM
Michael Robert A.	PRES & CHIEF OPERATING OFFICER	Feb 29 '24	Sale	176.45	68,879	12,153,957	98,645	Mar 01 05:50 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 29 '24	Sale	177.39	9,891	1,754,555	10,397	Mar 01 05:50 PM
GONZALEZ RICHARD A	CHAIRMAN OF THE BOARD AND CEO	Feb 28 '24	Sale	177.27	138,616	24,572,458	519,099	Mar 01 05:50 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 23 '24	Option Exercise	137.36	13,753	1,889,115	41,926	Feb 27 05:10 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 23 '24	Sale	177.51	13,753	2,441,295	28,173	Feb 27 05:10 PM
SALEKI-GERHARDT AZITA	EVP, CHIEF OPERATIONS OFFICER	Feb 21 '24	Option Exercise	58.88	52,870	3,112,986	296,814	Feb 23 05:00 PM
SALEKI-GERHARDT AZITA	EVP, CHIEF OPERATIONS OFFICER	Feb 21 '24	Sale	173.71	52,870	9,184,048	243,944	Feb 23 05:00 PM
Donoghoe Nicholas	EVP, CHIEF BUS/STRAT OFFICER	Dec 26 '23	Sale	154.72	2,912	450,545	55,903	Dec 28 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABBV

Abbvie Inc

Upgrade your FINVIZ experience